ðŸð± ç¬ç«ãã¥ãŒã¹ â 2026.04.12
ç¬8 + ç«5 = åèš13ä»¶
ðŸ ç¬ãã¥ãŒã¹ â 2026.04.12
æ¬æ¥ 8ä»¶
1. 𥩠æ é€ã»é£äºã»ãµããª
æ¥æ¬ã®åžè²©ãããããŒã100補åããPFASïŒæ°žé ã®ååŠç©è³ªïŒãæ€åºââæåªå€§åŠã®ç ç©¶ã飌ãäž»ã«èŠé
ð 2026.02.15
æåªå€§åŠã®ç ç©¶ããŒã ãæ¥æ¬åœå ã§è²©å£²ãããŠããç¬ç«çšãããããŒã100補åã察象ã«ã34çš®é¡ã®PFASïŒãã«ãã«ãªãã¢ã«ãã«ååç©çŸ€ãéç§°ãæ°žé ã®ååŠç©è³ªãïŒãåæããçµæãå€ãã®è£œåããPFASãæ€åºããããéããŒã¹ã®è£œåããã©ã€ããŒãã§ç¹ã«é«ãæ¿åºŠã確èªããããããŠã§ããããŒãã§ã¯1é£ãããã®æšå®æåéãããå€ããªãããšã倿ããã
ã³ã³ãããªã³ã¢ããã«ã¯äººéãšå®€å ç°å¢ãå ±æããŠãããè¡äžããæž¬å®å¯èœãªPFASãæ€åºããããå ±æé²ã®çªå µïŒã»ã³ããã«ïŒãã§ããããæ¯æ¥åã補åãé·æéæåãç¶ãããããã«ãšã£ãŠãæ¥åžžã®é£äºãæç¶çãªæé²çµè·¯ãšãªãå¯èœæ§ããããç ç©¶ããŒã ã¯ããããåãã®æ¯æ§è©äŸ¡ãšèŠå¶æŽåã®å¿ èŠæ§ã蚎ããŠããã
ð·ïž æ é€ã»é£äºã»ãµããª
2. ð ç¬åŠ
ã»ã©ããŒç¬ã粟ç¥ç§å ¥é¢æ£è ã®å€ç¬æãææã«è»œæžââVCU倧åŠã®åã®ã©ã³ãã 忝èŒè©Šéš
ð 2026.02.09
ããŒãžãã¢ã»ã³ã¢ã³ãŠã§ã«ã¹å€§åŠïŒVCUïŒã® Nancy Gee å士ãã®ç ç©¶ããŒã ãã粟ç¥ç§ã«å ¥é¢äžã®æäººæ£è 60åã察象ãšãã ã©ã³ãã 忝èŒè©Šéšã宿œããFrontiers in Psychiatry åã«çºè¡šãããåå è ã¯3æ¥éã«ããããæ¯æ¥20åéã®ã»ã©ããŒç¬èšªåããã³ãã©ãŒã®ã¿ã®èšªåããŸã ã¯éåžžæ²»çã®3矀ã«ç¡äœçºã«å²ãä»ããããã
ãã®çµæãã»ã©ããŒç¬ã䌎ã蚪åãå€ç¬æãæãææã«è»œæžãããèšåºçãªå·®ãçãã§ããã®ã¯ç¬ã®ååšãã®ãã®ããšç ç©¶è ã¯å ±åããŠãããç¹ã«ç¬ã®é£Œè²çµéšãããæ£è 矀ã§ã¯ãå€ç¬æã®æ¹åãããæç¶çã§ãã£ãããå€ç¬ã¯1æ¥15æ¬ã®å«ç ã«å¹æµããå¥åº·ãªã¹ã¯ããšãææãããŠãããåç©ä»åšä»å ¥ïŒAAIïŒã®æ²»ççãšããã³ã¹ãšããŠç»æçãªææã§ããã
3. ð¥ å»çã»çŸç ã»äºé²
ç¬ç±æ¥ã³ãããŠã€ã«ã¹HuPn-2018ãæ¬¡ã®ãã³ãããã¯åè£ã«ââCDCã蚺æäœå¶ã®ç©ºçœãã«èŠé
ð 2026.01.06
ç±³CDCã® Emerging Infectious Diseases åïŒ2026幎1æå·ïŒã«æ²èŒãããç·èª¬ã§ãç¬ç±æ¥ã³ãããŠã€ã«ã¹ HuPn-2018 ãšã€ã³ãã«ãšã³ã¶DãŠã€ã«ã¹ã®2ã€ããããã«ææãåŒåžåšçŸæ£ãåŒãèµ·ããæ°èãŠã€ã«ã¹ãšããŠæ³šç®ãããŠãããHuPn-2018ã¯ãã¬ãŒã·ã¢ã§èºçã®å°å ããåããŠåé¢ããããã®åŸãã€ãã»ã¿ã€ã»ç±³åœã»ãããã ã§ãæ€åºãããŠããããäžè¬çãªèšåºæ€æ»ã§ã¯å®å šã«èŠèœãšãããŠããã
èè ãã¯ãçŸåšãããã2ã€ã®ãŠã€ã«ã¹ã«å¯Ÿããæ¿èªæžã¿ã®æ€æ»ããããã¯ã¯ãã³ãååšããªãããšææãããâããææã®èœåãç²åŸãã€ã€ããå¯èœæ§ããããç£èŠäœå¶ã®æŽåãæ¥åã ãšããŠãããç¬ãšå¯æ¥ã«æ®ãã飌ãäž»ã«ãšã£ãŠãã人ç£å ±éææçãžã®æèãé«ãã奿©ãšãªãç ç©¶ã§ããã
ð https://wwwnc.cdc.gov/eid/article/32/1/25-1764_article
ð·ïž å»çã»çŸç ã»äºé²
4. ð¥ å»çã»çŸç ã»äºé²
ELIAS ããå ç«çæ³ãUSDAå®å šæ¿èªãååŸââç£å»çåã®é€å现èçæ³
ð 2026.03.10
ELIAS Animal Health瀟ã®ããå ç«çæ³ïŒECIïŒããUSDAçç©è£œå€ã»ã³ã¿ãŒïŒCVBïŒããå®å šæ¿èªãååŸãããããã¯ç£å»çã«ãããåã®æ¿èªæžã¿é€å现èçæ³ïŒadoptive cell therapyïŒã§ãããç¬ã®ããæ²»çã®æ°ããªãã€ã«ã¹ããŒã³ãšãªããECIã¯æ£è èªèº«ã®å ç«çްèãäœå€ã§æŽ»æ§åããŠè «çãšæŠãããææ³ã§ãåŸæ¥ã®ååŠçæ³ãæŸå°ç·çæ³ãšã¯ç°ãªãã¢ãããŒããæäŸããã
åæã«ãcaninizedïŒç¬ååïŒæPD-1ã¢ãã¯ããŒãã«æäœ gilvetmab ãè¥æºçްèè «ã»ã¡ã©ããŒãã«å¯Ÿããæ¡ä»¶ä»ãæ¿èªãåããŠãããç¬ã®ããã«å¯Ÿããå ç«çæ³ã®éžæè¢ãæ¥éã«æ¡å€§ããŠãããããã®æ©æçºèŠãšç£å»åž«ãžã®çžè«ããŸããŸãéèŠã«ãªã£ãŠããã
ð https://www.dvm360.com/view/usda-approves-new-canine-cancer-therapy
ð·ïž å»çã»çŸç ã»äºé²
5. ð ç¬åŠ
è±åœãæè³ã»æå°Ÿãããç¬ã®èŒžå ¥ãå šé¢çŠæ¢ââ2026幎1æ1æ¥æœè¡ã®æ°åç©çŠç¥æ³
ð 2026.01.01
è±åœã¯2026幎1æ1æ¥ãããçŸå®¹ç®çã§æè³ïŒear croppingïŒãæå°ŸïŒtail dockingïŒãæœãããç¬ã®èŒžå ¥ãå šé¢çŠæ¢ãšãªã£ããåæ³ã§ã¯åç¬ã®èŒžå ¥æäœæéœ¢ã6ã¶æã«åŒãäžãããããããŒãã¡ãŒã ããã®å®æãªèŒžå ¥ã鲿¢ããçãããããéåè ã«ã¯å³ãã眰åãç§ãããã
æè³ãæå°Ÿã¯è±åœåœå ã§ã¯æ¢ã«éæ³ã ã£ãããæµ·å€ã§æœè¡ãããç¬ã®èŒžå ¥ã«ã¯æã穎ãååšããŠãããä»åã®æ³æ¹æ£ã§ãã®ãã«ãŒãããŒã«ããå®å šã«å¡ããã圢ãšãªããEUã§ã2025幎11æã«ç¬ç«ã®çŠç¥ã«é¢ããçµ±äžåºæºã®æ«å®åæãæç«ãã2026幎ååã«æ¬§å·è°äŒã§æç¥šäºå®ã§ããããšãŒãããå šäœã§åç©çŠç¥ã®æ³çæŽåãå éããŠããã
ð https://claredogtraining.com/uk-import-ban-on-cropped-and-docked-dogs-begins-in-2026/
6. 𧬠ç ç©¶ã»ç§åŠ
ããã»ããé§é€è¬ãéççç©ã«æ³å®å€ã®æªåœ±é¿ââã€ãœããµãŸãªã³ç³»è¬å€ã®ç°å¢æåºãå調æ»
ð 2026.02.21
2026幎2æã« ScienceDaily ã§å ±ããããç ç©¶ã«ãããšãç¬ç«ã«åºãåŠæ¹ãããŠããã€ãœããµãŸãªã³ç³»ã®ããã»ããé§é€è¬ïŒãã«ã©ã©ãã«ãã¢ãã©ããœã©ãã«ãªã©ïŒãããããã®äœå ã§ä»£è¬ãããåŸã«ç³äŸ¿ãéããŠç°å¢äžã«æåºãããæšçå€ã®æè«ã«ãæ¯æ§ãåãŒããŠããå¯èœæ§ã瀺ãããã
æè¬ãåãããããã®ææ³ç©ãåå£ãæ°Žç°å¢ã«å°éãããšãçæ ç³»ã®éèŠãªæè«ââèèãè±ç²åªä»è ââã«ã圱é¿ãåã¶æãããããé§é€è¬ã®å¹æã¯é£Œãäž»ã«ãšã£ãŠäžå¯æ¬ ã ããç°å¢ãžã®åœ±é¿ãæå°åããæ¹æ³ïŒææ³ç©ã®é©åãªåŠçãªã©ïŒãä»åŸã®èª²é¡ãšããŠç ç©¶è ã¯ææããŠãããç£å»åž«ã«çžè«ããªãããé©åãªè£œåéžæãå¿ããããã
ð https://www.sciencedaily.com/releases/2026/02/260221000328.htm
7. ð¥ å»çã»çŸç ã»äºé²
CAPC 2026幎äºå ±ïŒã©ã€ã ç ã»ãšãŒãªãã¢çã»ã¢ããã©ãºãçã®ææãªã¹ã¯ãå šç±³ã§æ¡å€§åŸå
ð 2026.03.15
ç±³åœã³ã³ãããªã³ã¢ããã«å¯çè«åŠäŒïŒCAPCïŒãçºè¡šãã2026幎ã®å¯çè«ãªã¹ã¯äºå ±ã«ãããšãã©ã€ã ç ããšãŒãªãã¢çãã¢ããã©ãºãçãªã©ã®ãããåªä»çŸæ£ã®ãªã¹ã¯ãå šç±³èŠæš¡ã§æ¡å€§ããŠãããç¹ã«ããŒã³ã¹ã¿ãŒãããã®çæ¯åãäžè¥¿éšäžéšãããã¥ãŒã€ã³ã°ã©ã³ãã«ãããŠåäžããŠããããããŸã§äœãªã¹ã¯ã ã£ãå°åã®é£Œãäž»ã«ã泚æãå¿ èŠãšãªã£ãŠããã
æž©æåã«ããå¬å£ã®æ°æž©äžæãããããã®æŽ»åæéãå®è³ªçã«é幎åããã€ã€ããããããã¯è¯æ°40床ïŒçŽ4.4âïŒã§ã掻åå¯èœã§ããããæ¥ã«ãªã£ããäºé²ãå§ããããšããåŸæ¥ã®èãæ¹ã§ã¯äžååã幎éãéããäºé²è¬ã®æäžãšå®æçãªæ€æ»ãæšå¥šããããæ£æ©åŸã®ãããã§ãã¯ãç¿æ £åãããã
ð·ïž å»çã»çŸç ã»äºé²
8. ð¥ å»çã»çŸç ã»äºé²
ç¬ã®æ ¢æ§çŒçã®ç¥çµçç©åŠççè§£ãåé²ââFrontiersèªãQOLè©äŸ¡æ³ã®å æ¬çã¬ãã¥ãŒãå ¬é
ð 2026.03.28
Frontiers in Animal Science åïŒ2026幎ïŒã«æ²èŒããããã©ãã£ãã¬ãã¥ãŒããç¬ã®æ ¢æ§çŒçã«ãããç¥çµçç©åŠçã¡ã«ããºã ãšQOLïŒç掻ã®è³ªïŒè©äŸ¡æ³ãå æ¬çã«æŽçãããæ ¢æ§çã§ã¯æ«æ¢¢æäœãšäžæ¢æäœãæç¶çã«èµ·ãããçã¿ã®å容äœãéæåããããšã§ãããããªåºæ¿ã§ãæ¿ããçã¿ãšããŠèªèãããããã©ã¢ãããã£ããã€ã³ïŒé©å¿äžå šæ§çŒçïŒãç¶æ ã«é¥ãããšã詳述ãããŠããã
ããã«ãå 霢ã«äŒŽãè žå 现èå¢ãå ç«ãã©ã³ã¹ãç¥çµæ é€å åã·ã°ãã«ã®å€åãšæ ¢æ§çŒçã®é¢é£ã瀺åããããç¬ã®é«éœ¢åã«äŒŽãå€åœ¢æ§é¢ç¯çãªã©ã®æ ¢æ§çãæ±ããç¬ã¯å¢å ããŠãããæ©æçºèŠã®ããã®è¡åå€åã®èгå¯ïŒæ£æ©ãå«ãããéæ®µãé¿ãããè§Šããããšæããªã©ïŒã飌ãäž»ã«ãšã£ãŠéèŠãç£å»åž«ãžã®æ©ãã®çžè«ãå§ããã
ð https://www.frontiersin.org/journals/animal-science/articles/10.3389/fanim.2026.1751141/full
ð·ïž å»çã»çŸç ã»äºé²
ð± ç«ãã¥ãŒã¹ â 2026.04.12
æ¬æ¥ 5ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
Felycin-CA1ïŒã·ããªã ã¹ïŒãFDAæ¡ä»¶ä»ãæ¿èªââç«ã®è¥å€§åå¿ççïŒHCMïŒã«åã®æ²»çè¬
ð 2026.01.22
ç±³FDAã Felycin-CA1ïŒã·ããªã ã¹åŸæŸé²ïŒããç¡çåæ§è¥å€§åå¿ççïŒHCMïŒã®ç«ã«ãããå¿å®€è¥å€§ã®ç®¡çã«å¯ŸããŠæ¡ä»¶ä»ãæ¿èªãããããã¯ç£å»çã«ãããåã®æ¿èªæžã¿é€å现èçæ³ïŒadoptive cell therapyïŒã§ãããç¬ã®ããæ²»çã®æ°ããªãã€ã«ã¹ããŒã³ãšãªããECIã¯æ£è èªèº«ã®å ç«çްèãäœå€ã§æŽ»æ§åããŠè «çãšæŠãããææ³ã§ãåŸæ¥ã®ååŠçæ³ãæŸå°ç·çæ³ãšã¯ç°ãªãã¢ãããŒããæäŸããã
æå¹æåã®ã©ããã€ã·ã³ïŒã·ããªã ã¹ïŒã¯mTORçµè·¯ãé»å®³ããããšã§çްè墿®ãšè¥å€§ãå¶åŸ¡ãããå¿äžå šã«è³ãåã®ãç¡çåæãã«ä»å ¥ã§ããç¹ãç»æçã§ãããæ©æã¹ã¯ãªãŒãã³ã°ã®éèŠæ§ããŸããŸãé«ãŸããç«ã®å¥åº·èšºæã§ãšã³ãŒæ€æ»ã宿çã«åããããšãããã®æ°è¬ã®æ©æµãæå€§åããéµãšãªããç£å»åž«ã«çžè«ãã
ð·ïž å»çã»çŸç ã»äºé²
2. ð¥ å»çã»çŸç ã»äºé²
æ ¢æ§äžç¢ã®ç«ã®65%ãç«ã³ãããŠã€ã«ã¹éœæ§ââ493é ã®èª¿æ»ã§ãèŠéããããç åäœããæµ®äž
ð 2026.04.07
2026幎4æã«å ±ããããç ç©¶ã§ãæç¶çãªäžç¢ã瀺ãç«493é ã調æ»ãããšãããçŽ65%ãç«ã³ãããŠã€ã«ã¹ïŒFCoVïŒéœæ§ã§ããããšã倿ãããFCoVã¯äžè¬çã«è»œãè žçãåŒãèµ·ããããäžéšãå€ç°ãããšèŽæ»çãªç«äŒææ§è ¹èçïŒFIPïŒã«é²è¡ãããä»åã®ç ç©¶ã¯FIPã§ã¯ãªãããæ¥åžžçãªæ ¢æ§äžç¢ãã«FCoVãæ·±ãé¢äžããŠããå¯èœæ§ã瀺ããç¹ã§éèŠã§ããã
æ ¢æ§äžç¢ã¯åå äžæãšãããã¡ã ããFCoVæ€æ»ãç©æ¥µçã«è¡ãããšã§é©åãªç®¡çãå¯èœã«ãªããå€é 飌ãã®å®¶åºã§ã¯ãŠã€ã«ã¹ã®äŒæãªã¹ã¯ãé«ãŸãããããã€ã¬ã®è¡ç管çãç¹ã«éèŠãäžç¢ã2é±é以äžç¶ãå Žåã¯ç£å»åž«ã«FCoVæ€æ»ã«ã€ããŠçžè«ããããšãå§ããããã
ð·ïž å»çã»çŸç ã»äºé²
3. ð¥ å»çã»çŸç ã»äºé²
H5N1é³¥ã€ã³ãã«ãšã³ã¶ãç«ã«ãæ·±å»ãªè åšââMorris Animal Foundationãæ°ç ç©¶ã«è³éæäŸ
ð 2026.03.20
Morris Animal Foundationã¯2026å¹Žã®æ°èŠå©æãããžã§ã¯ããšããŠãç«ã«ãããH5N1é«ç åæ§é³¥ã€ã³ãã«ãšã³ã¶ïŒHPAIïŒã®ç ç©¶ãéå§ãããææããé³¥ãæªå ç±ã®é³¥èã»ä¹³è£œåãæåããç«ãé節ãªå šèº«ææãèµ·ãããäºäŸãå ±åãããŠãããç«ã¯ä»ã®åºä¹³é¡ãšæ¯ã¹ãŠH5N1ã«å¯Ÿããæåæ§ãé«ãå¯èœæ§ãããã
H5N1ã®ç«ãžã®ææãæ¡å€§ããã°ãç«ãããããžã®äŒæãªã¹ã¯ãæžå¿µããããç ç©¶ããŒã ã¯å¹æçãªæ²»çæ³ã®ç¢ºç«ãç®æããŠãããæåããã°ã¯ã³ãã«ã¹ïŒOne HealthïŒã®èгç¹ãããéèŠãªææãšãªãã飌ãäž»ãšããŠã¯ãç«ãå®å šå®€å 飌ãã«ãããéé³¥ãšã®æ¥è§Šãé¿ãããæªå ç±ã®é³¥èãäžããªããªã©ã®åºæ¬çãªäºé²çã培åºãããã
ð·ïž å»çã»çŸç ã»äºé²
4. ð§ ãã¬ãŒãã³ã°ã»è¡åç§åŠ
åç«æã®ç€ŸäŒåãã¬ãŒãã³ã°ããèªç¥ãã€ã¢ã¹ãã«ãŸã§åœ±é¿ââæ©æä»å ¥ã®é·æå¹æãå®èšŒ
ð 2025.12.18
Frontiers in Ethology åã«æ²èŒãããç ç©¶ããåç«ã®ç€ŸäŒåã¯ã©ã¹ãžã®åå ãèªç¥ãã€ã¢ã¹ïŒæ¥œèгç/æ²èгçãªå€æåŸåïŒãšåŒå¥åŠç¿ã«äžãã圱é¿ã調æ»ããã瀟äŒåãåããåç«ã¯ãææ§ãªåºæ¿ã«å¯ŸããŠãããæ¥œèгçããªåå¿ã瀺ãåŸåããããæ°ããç°å¢ãç¶æ³ã«å¯Ÿããã¹ãã¬ã¹èæ§ãé«ãããšã瀺åãããã
ç«ã®ç€ŸäŒåã®æåæã¯çåŸ2ïœ7é±éãšããããããã®åŸã®äœç³»çãªãã¬ãŒãã³ã°ãèªç¥çãªæè»æ§ã®çºéã«å¯äžãããããã«å¥ã®ç ç©¶ã§ã¯ã瀟äŒåãããç«ã¯é£ç©ç²åŸã¿ã¹ã¯ãããéã解決ããããšã確èªãããŠãããæ°ããåç«ãè¿ãã飌ãäž»ã¯ãæ©ã段éãã倿§ãªäººã»ç°å¢ã»é³ãžã®ç©ãããªæé²ãå¿ããããšãçæ¶¯ã«ãããã¡ã³ã¿ã«ãã«ã¹ã®åºç€ãç¯ãã
ð https://www.frontiersin.org/journals/ethology/articles/10.3389/fetho.2025.1681085/full
5. ð± ç«åŠ
ç±³åœã®åç©ã·ã§ã«ã¿ãŒå±æ©ãæ·±å»åââãè²æž¡ãããã飌ãç¶ããããæ¯æŽããžè»¢æããæ°ã¢ãããŒã
ð 2026.03.25
ç±³åœã®åç©ä¿è·æœèšã§ã¯è²æž¡çã®äœäžãšå容æ°ã®å¢å ãæ·±å»åããŠãããSecond Chance Animals ãªã©ã®å£äœã¯åŸæ¥ã®ãè²æž¡ä¿é²ãã¢ãã«ããããããããææŸããã«æžãæ¯æŽããžã®è»¢æãé²ããŠããã圌ãã® Access to Care ããã°ã©ã ã¯ãäœã³ã¹ãã®ç£å»çãã¯ã¯ãã³ã¯ãªããã¯ããããããŒãæ¯æŽãªã©ãæäŸããçµæžççç±ã«ããæŸæ£ãæªç¶ã«é²ãã
ãããæŸæ£ã®æå€§ã®çç±ã¯ãè³æºã®äžè¶³ãã§ãããã±ã¢ãžã®ã¢ã¯ã»ã¹éå£ãåãé€ãããšãéå°åå®¹ã®æ ¹æ¬çãªè§£æ±ºçãšãªãã2026幎ã«ã¯å°ãªããšã12ã®å·ã§ããããå ±çå¯èœäœå® ãããç£å»çã¢ã¯ã»ã¹æ¹åãã«é¢ããç«æ³ãã£ã³ããŒã³ãé²è¡äžãç«ã®é£Œãäž»ãšããŠãå°åã®ä¿è·å£äœãTNR掻åãžã®æ¯æŽã鿥çã«å šãŠã®ç«ã®çŠç¥åäžã«ã€ãªããã
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ç«ã®HCMã¯ãæ²é»ã®ç ãââçç¶ãåºãåã«æ²»çãå§ããããæä»£ãå°æ¥ããŸããã幎ã«äžåºŠã®ãšã³ãŒæ€æ»ããæç«ã®åœãæãç¬¬äžæ©ã§ãã
æ¯æ7æé ä¿¡

ã³ã¡ã³ããæ®ã